{"id":6646,"date":"2024-03-04T01:34:47","date_gmt":"2024-03-04T01:34:47","guid":{"rendered":"https:\/\/economicherald.net\/?p=6646"},"modified":"2024-03-04T01:34:47","modified_gmt":"2024-03-04T01:34:47","slug":"asx-health-stocks-polynovo-to-get-first-orders-in-india-clinuvel-reports-good-results-from-phase-2","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=6646","title":{"rendered":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2"},"content":{"rendered":"<p>Polynovo to get first orders of NovoSorb BTM in India<br \/>\nClinuvel Pharma reports positive results from Phase 2 study<\/p>\n<p>\u00a0<\/p>\n<h2><strong>Polynovo approved for Indian government e-portal site<\/strong><\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/polynovo-pnv\/\">Polynovo (ASX:PNV)<\/a><\/strong> announced that the Indian government has approved <strong>NovoSorb BTM<\/strong> to be included in the <em>Government-e-Marketplace (GeM)<\/em> portal.<\/p>\n<p>GeM is a centralised procurement platform for government hospitals that can now buy NovoSorb BTM throughout India.<\/p>\n<p>This approval provides access to supply BTM across all the Defence hospitals, railways hospitals, ESIC (Employees State Insurance Corporation) hospitals, and the various AIIMS (All India Institute of Medical Sciences) hospitals.<\/p>\n<p>Polynovo expects the first order within a month.<\/p>\n<p>The company\u2019s NovoSorb BTM is a <strong>dermal scaffold<\/strong> for the regeneration of the dermis when lost through extensive surgery, trauma or burn. It\u2019s made from a novel range of bio-resorbable polymers that can be produced in many formats including film, fibre, foam, and coatings.<\/p>\n<p>\u201cOur India team is optimistic we can win a number of other tenders that will open the doors of public hospitals for BTM,\u201d said <em>Polynovo chairman, David Williams.<\/em><\/p>\n<p>\u00a0<\/p>\n<h2>Clinuvel reports positive results from Phase 2 trial<\/h2>\n<p>Meanwwhile, <strong><a href=\"https:\/\/stockhead.com.au\/company\/clinuvel-pharmaceuticals-cuv\/\">Clinuvel Pharma (ASX:CUV)<\/a><\/strong> announced positive results from its first <strong>Phase 2 study evaluating SCENESSE<\/strong> (afamelanotide 16mg), as a treatment for <strong>variegate porphyria (VP)<\/strong> patients.<\/p>\n<p>Analyses from the <strong>CUV040<\/strong> study showed that SCENESSE provides systemic photoprotection to VP patients, reducing disease severity and clinical symptoms, and improving patients\u2019 quality of life.<\/p>\n<p>VP is a metabolic disorder which leads to the accumulation and storage of excessive porphyrin intermediates in the skin and liver. For people living with this condition, sun and light exposure can cause severe dermatological symptoms such as dermal lesions, ulcers, and blistering.<\/p>\n<p>The six-month CUV040 study had evaluated whether the drug could offer <strong>systemic photoprotection<\/strong> to VP patients and reduce the impact of dermatological symptoms.<\/p>\n<p>Six adult VP patients with active dermal symptoms were enrolled and commenced treatment in the spring and summer months, receiving six SCENESSE doses and completing all study visits.<\/p>\n<p>All six patients experienced a positive change \u2013 improvement up to three times baseline scores \u2013 in disease severity after treatment.<\/p>\n<p>The average <strong>CGIC (Clinical Global Impression of Change)<\/strong> change \u2013 which was the primary endpoint of the study \u2013 was rated as <strong>\u201cmuch improved\u201d,<\/strong> with first changes observed as early as four weeks after the first treatment.<\/p>\n<p>All patients also experienced decreased fragility of sun exposed skin following treatment.<\/p>\n<p>\u201cThese results give us the momentum to continue the development program for VP,\u201d said <em>Clinuvel\u2019s head of Clinical Operations, Dr Pilar Bilbao.<\/em><\/p>\n<p>\u201cIt will establish a larger clinical trial program and subsequently preparing and filing a marketing authorisation application.\u201d<\/p>\n<p>\u00a0<\/p>\n<h2>Share prices today:<\/h2>\n<p>\u00a0<\/p>\n\n<p><span class=\"mce_SELRES_start\">\ufeff<\/span><span class=\"mce_SELRES_start\"><\/span>\u00a0<br \/>\n<span class=\"et_bloom_bottom_trigger\"><\/span><\/p>\n<p>The post <a href=\"https:\/\/stockhead.com.au\/health\/asx-health-stocks-polynovo-to-get-first-orders-in-india-clinuvel-reports-good-results-from-phase-2\/\">ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2<\/a> appeared first on <a href=\"https:\/\/stockhead.com.au\/\">Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Polynovo to get first orders of NovoSorb BTM in India Clinuvel Pharma reports positive results from Phase 2 study \u00a0 Polynovo approved for Indian government <a href=\"https:\/\/economicherald.net\/?p=6646\" class=\"read-more-link\">[more&#8230;]<\/a><\/p>\n","protected":false},"author":0,"featured_media":6647,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-6646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=6646\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Polynovo to get first orders of NovoSorb BTM in India Clinuvel Pharma reports positive results from Phase 2 study \u00a0 Polynovo approved for Indian government [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=6646\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-04T01:34:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2\",\"datePublished\":\"2024-03-04T01:34:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646\"},\"wordCount\":474,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=6646\",\"name\":\"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg\",\"datePublished\":\"2024-03-04T01:34:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=6646\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=6646#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=6646","og_locale":"en_US","og_type":"article","og_title":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald","og_description":"Polynovo to get first orders of NovoSorb BTM in India Clinuvel Pharma reports positive results from Phase 2 study \u00a0 Polynovo approved for Indian government [more...]","og_url":"https:\/\/economicherald.net\/?p=6646","og_site_name":"Economic Herald","article_published_time":"2024-03-04T01:34:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=6646#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=6646"},"author":{"name":"","@id":""},"headline":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2","datePublished":"2024-03-04T01:34:47+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=6646"},"wordCount":474,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=6646#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=6646","url":"https:\/\/economicherald.net\/?p=6646","name":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2 - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=6646#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=6646#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg","datePublished":"2024-03-04T01:34:47+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=6646#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=6646"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=6646#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/03\/Polynovo-to-get-first-orders-of-NovoSorb-BTM-in-India.-Picture-Getty-y5WDlm.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=6646#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/6646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6646"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/6646\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/6647"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}